If June (practically around the door) is expected to be the end...

If June (practically around the door) is expected to be the end of the recruiting, and the IIIQ a period for trial completion and data assembling, I expect that we will at 0.20 (four times today value) by the end of July. Then with a consolidation of current good result by end of July, we can expect a second step staircase raise after 3Q. A Partnering announcement and the communication to the market of a major cash infusion could bring us in the upper side toward a successful and very good investor level of 1. The name and solidity of the partner will be the blockbuster biotech announcement in Australia for 2018. We will see.